Fluarix Quadrivalent Generic Name & Formulations
Quadrivalent inactivated "split virus" influenza vaccine (types A and B); contains a total of 60mcg hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; may contain trace amounts of hydrocortisone, gentamicin, others; preservative-free.
Single-dose prefilled Tip-Lok syringes (0.5mL)—10
Fluarix Quadrivalent Indications
Fluarix Quadrivalent Dosage and Administration
Adults and Children
<6mos: not established. Each dose is 0.5mL by IM inj once in the anterolateral thigh (6–11mos) or the deltoid (≥12mos). 6mos–8yrs (previously unvaccinated): 2 doses, give at least 4 weeks apart; (vaccinated in a previous season): 1 or 2 doses (depending on vaccination history as per annual ACIP recommendation); if 2 doses, give at least 4 weeks apart. ≥9yrs: 1 dose.
Fluarix Quadrivalent Contraindications
Allergy to egg protein or following a previous flu vaccine administration.
Fluarix Quadrivalent Boxed Warnings
Fluarix Quadrivalent Warnings/Precautions
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Risk of sycope with injectable vaccines. Have epinephrine inj (1:1000) available. Pregnancy. Nursing mothers.
Fluarix Quadrivalent Pharmacokinetics
Fluarix Quadrivalent Interactions
Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may result in suboptimal response.
Fluarix Quadrivalent Adverse Reactions
Local reactions (eg, redness, swelling, pain), muscle aches, fatigue, headache, arthralgias, GI symptoms, shivering, fever; children: irritability, loss of appetite, drowsiness.
Fluarix Quadrivalent Clinical Trials
Fluarix Quadrivalent Note
Fluarix Quadrivalent Patient Counseling